Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$462M |
| 2 |
NVIDIA
NVDA
|
+$385M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Apple
AAPL
|
+$301M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
ExxonMobil
XOM
|
+$352M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
| 5 |
SoFi Technologies
SOFI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 18.32% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Compass Minerals
CMP
$1.23B
| $6.13M | ﹤0.01% |
544,818
-528
| -0.1% | -$6.89K |
|
2477
Hippo Holdings
HIPO
$777M
| $6.11M | ﹤0.01% |
228,137
+112,108
| +97% | +$2.76M |
|
|
NOVA
2478
DELISTED
Sunnova Energy
NOVA
| $6.04M | ﹤0.01% |
1,760,198
+768,803
| +78% | +$3.85M |
|
2479
AMREP Corp
AXR
$124M
| $6.03M | ﹤0.01% |
191,958
+10,758
| +6% | +$347K |
|
2480
AstroNova
ALOT
$223M
| $6.03M | ﹤0.01% |
501,755
-6,510
| -1% | -$91.6K |
|
2481
Cooper-Standard Automotive
CPS
$517M
| $6.02M | ﹤0.01% |
443,700
-6,538
| -1% | -$93.5K |
|
2482
Companhia Siderúrgica Nacional
SID
$1.37B
| $5.99M | ﹤0.01% |
4,160,777
-207,768
| -5% | -$407K |
|
2483
Bally's
BALY
$708M
| $5.96M | ﹤0.01% |
332,880
| – | – |
|
2484
EverQuote
EVER
$949M
| $5.95M | ﹤0.01% |
297,801
+35,152
| +13% | +$664K |
|
2485
MaxCyte
MXCT
$108M
| $5.94M | ﹤0.01% |
1,429,071
+191,088
| +15% | +$722K |
|
2486
Stoke Therapeutics
STOK
$1.84B
| $5.94M | ﹤0.01% |
538,900
+273,890
| +103% | +$3.36M |
|
2487
Pure Cycle
PCYO
$255M
| $5.92M | ﹤0.01% |
466,795
+6,387
| +1% | +$78K |
|
|
TBCH
2488
Turtle Beach Corp
TBCH
$238M
| $5.9M | ﹤0.01% |
340,866
-3,438
| -1% | -$56.2K |
|
|
KALV
2489
DELISTED
KalVista Pharmaceuticals
KALV
| $5.9M | ﹤0.01% |
696,037
+89,001
| +15% | +$922K |
|
2490
DHI Group
DHX
$177M
| $5.84M | ﹤0.01% |
3,298,638
-154,517
| -4% | -$273K |
|
|
CFLT
2491
DELISTED
Confluent
CFLT
| $5.82M | ﹤0.01% |
208,043
+60,346
| +41% | +$1.62M |
|
2492
Travelzoo
TZOO
$76.7M
| $5.81M | ﹤0.01% |
291,444
-11,188
| -4% | -$193K |
|
2493
Cogent Biosciences
COGT
$6.76B
| $5.8M | ﹤0.01% |
743,652
-48,771
| -6% | -$486K |
|
2494
Oric Pharmaceuticals
ORIC
$1.17B
| $5.79M | ﹤0.01% |
717,188
+103,237
| +17% | +$947K |
|
2495
BCE
BCE
$20.8B
| $5.79M | ﹤0.01% |
249,747
+11,746
| +5% | +$338K |
|
2496
Dave Inc
DAVE
$4.82B
| $5.76M | ﹤0.01% |
+66,245
| New | +$4.44M |
|
2497
Ouster
OUST
$2.11B
| $5.76M | ﹤0.01% |
471,020
+85,355
| +22% | +$750K |
|
2498
Dine Brands
DIN
$462M
| $5.72M | ﹤0.01% |
190,145
+14,958
| +9% | +$481K |
|
2499
Frontier Group Holdings
ULCC
$1.49B
| $5.72M | ﹤0.01% |
804,693
+545,485
| +210% | +$3.4M |
|
|
FONR
2500
DELISTED
Fonar
FONR
| $5.7M | ﹤0.01% |
376,678
+2,149
| +0.6% | +$33.4K |
|
Similar funds
Dimensional Fund Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
- Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
- Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
- Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
- Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
- Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.